Q3 2025 Neogen Chemicals Ltd Earnings Call Transcript
Key Points
- Neogen Chemicals Ltd (BOM:542665) reported a 22% growth in revenue and a 71% improvement in EBITDA, showcasing strong operational performance.
- The company successfully launched new products and expanded its export opportunities, demonstrating a commitment to innovation and global expansion.
- The amalgamation of July Chemicals India Private Limited with Neogen Chemicals is expected to streamline operations, reduce costs, and enhance market position in Pharma and Agrochemicals.
- Neogen Chemicals has commenced exports to Europe, Korea, and Japan, opening new avenues for growth.
- The company is strategically diversifying its revenue streams by shifting focus to sectors like semiconductors, flavors and fragrances, and industrial custom manufacturing.
- The pricing environment remains depressed, and ongoing global headwinds pose challenges to maintaining top-line growth.
- There is a delay in the approval process for international customers, affecting the timeline for commercial sales of battery chemicals.
- The company faces challenges in the Agrochemical sector, requiring a strategic shift to other end-use sectors.
- The battery chemicals business is experiencing slower-than-expected demand pickup, impacting revenue projections for the current financial year.
- Neogen Chemicals is dealing with increased depreciation and higher interest expenses due to ongoing CapEx in the Neogen Ionic segment.
Ladies and gentlemen, good day and welcome to Newgen Chemicals Limited Q3 F I 25 earnings conference call.
As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes.
Should you need assistance during the conference call? Please signal an operator by pressing star then zero on your touchtone phone.
Please note that this call is being recorded.
I now hand the conference over to Mr Nishid Solanki from Syria, India. Thank you and over to you.
Thank you. Good evening, everyone and welcome to News and Chemicals Q3 F I 25 earnings conference call for analysts and investors. Today, we are joined by senior members of the management team including Dr Haren Kanani, managing director, Mr Anura Surana, director and Mr Gopi Krishnan Pai, Chief Financial Officer. We will commence the call with opening thoughts from the management team post which we shall open the forum for Q&A where the management will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
